Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Microbial Asymmetric Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1840671A details a bio-catalytic route for (R)-mandelic acid using Brevibacterium flavum. Offers high optical purity and greener manufacturing for pharmaceutical supply chains.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.